The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Tralieve 80 mg chewable tablets for dogs

Dechra Regulatory B.V.VPA22622/039/002

Main Information

Trade NameTralieve 80 mg chewable tablets for dogs
Active SubstancesTramadol hydrochloride
Dosage FormChewable tablet
Licence HolderDechra Regulatory B.V.
Licence NumberVPA22622/039/002

Group Information

ATC CodeQN02AX02 tramadol
Therapeutic ClassAnaesthetic/Analgesic


License statusAuthorised
Licence Issued06/07/2018
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back